Weekly Roundup: June 16-22, 2023
Harvard Corporate Governance
JUNE 23, 2023
Key Components and Trends of CVRs in Life Sciences Public M&A Deals Posted by Sally Wagner Partin, Sharon Flanagan, and Hannah M. Groner, Katherine L. Romain, Michael P.
Harvard Corporate Governance
JUNE 23, 2023
Key Components and Trends of CVRs in Life Sciences Public M&A Deals Posted by Sally Wagner Partin, Sharon Flanagan, and Hannah M. Groner, Katherine L. Romain, Michael P.
Benzinga
SEPTEMBER 28, 2022
OTCQB: SILFF ) (CSE: SILO) (FSE: 3K7A) is acquiring Dyscovry Science Ltd. , According to information procured exclusively by Benzinga ahead of an official announcement , global psychedelics company Silo Wellness Inc. of National Policy 46-201- Escrow for Initial Public Offerings. Full story available on Benzinga.com.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cooley M&A
JANUARY 23, 2024
In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. Why did life sciences outperform the market? More than half of all life sciences M&A activity in 2023 was for private and small-cap biopharma sellers.
Benzinga
OCTOBER 11, 2023
Before his career in High-Tech, he had a 13-year career in medical science. Rene Sindlev, Chair of the Board of Renovaro Biosciences, said, "Avram's unique background in medical science and technology and, in particular, his experience dealing with the opportunities fueled by rapid technological changes will help guide our business.
Benzinga
JULY 19, 2023
Presentation slides will be made available through the investor section of the Company's Home Page here. ENDS - About Sosei Heptares Sosei Heptares is a fully integrated biopharmaceutical company focused on bringing life-changing medicines based on world-class science to patients globally. Our vision is to become.
Benzinga
MAY 18, 2022
Complete Hemp/Cannabis Solution from Receptor Science and Plant Genetics to Final Ingredients and CDMO. Consistent, Reliable, High-Quality Cannabinoids and Cannabinoid Infused Products for Consumers. Acquisition Immediately Accretive; Will Double 22nd Century Revenue. BUFFALO, N.Y., May 18, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc.
Benzinga
AUGUST 18, 2022
Research Department, Mineral Science. Section, Project No. Previous work by QIT Iron and Titanium in 1980-1981 consisted of 56 drill holes which outlined a historical non-NI 43-101 compliant resource of +23,405,000 tonnes grading 20.5% MgO, 30.5% CaO and 0.92% SiO 2 (QIT-Fer et Titane inc., Cossette, December 11, 1981). Marleau, D.Sc.,
Let's personalize your content